Australia's Living Cell Tech jumps on Parkinson's disease trail progress

Algorae Pharmaceuticals

19/06/2023 04:09

** Shares of Australia's Living Cell Technologies  LCT.AX 
up 8.3% to A$0.013, coming off a two-day halt
    ** The biotech firm finalises all aspects of a pig herd and
surgical facility in New Zealand  urn:newsml:reuters.com:*:nASXbjcG24
    ** Facility to make NTCELL tissues, dedicated to treating
Parkinson's disease, for use in upcoming third clinical trial
    ** Trading vol of 577,200 shares closing in on 30-day avg of
~629,000 shares
    ** Stock up 1.25% this year, as of last close, vs a 3.02%
increase in the benchmark S&P/ASX 200 index  .AXJO 

 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))